AmerisourceBergen Ruling Sharpens Del.'s Compliance Focus
The Delaware Supreme Court's revival of a multibillion-dollar stockholder derivative suit against drug giant AmerisourceBergen Corp. has heightened court concern for assuring fiduciary loyalty and care compliance among state-chartered companies caught...To view the full article, register now.
Already a subscriber? Click here to view full article